(Q45100299)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15476476%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

title

De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15476476%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

main subject

kidney transplantation

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15476476%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

11

Daniel R Salomon

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15476476%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

author name string

Stuart M Flechner

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15476476%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Kim Solez

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15476476%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Daniel J Cook

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15476476%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

James T Burke

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15476476%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Hank Rollin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15476476%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Jennifer A Hammond

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15476476%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Thomas Whisenant

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15476476%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Caroline M Lanigan

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15476476%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Steven R Head

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15476476%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

language of work or name

English

0 references

publication date

1 November 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15476476%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Transplantation

3 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15476476%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15476476%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15476476%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

page(s)

1776-1785

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15476476%20AND%20SRC:MED&resulttype=core&format=json

Outcome of cadaveric renal transplant patients treated for 10 years with cyclosporine: is chronic allograft nephropathy the major cause of late graft loss?

3 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00627.X

Determinants of chronic renal allograft rejection in cyclosporine-treated recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00627.X

Cyclosporin A in patients receiving renal allografts from cadaver donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00627.X

Chronic rejection and chronic cyclosporin toxicity in renal allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00627.X

The natural history of chronic allograft nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00627.X

Chronic renal failure after transplantation of a nonrenal organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00627.X

Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00627.X

Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00627.X

Molecular mechanisms of renal allograft fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00627.X

Combination therapy of mycophenolate mofetil and rapamycin in prevention of chronic renal allograft rejection in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00627.X

Combination therapy with sirolimus and mycophenolate mofetil: effects on the kidney and on transforming growth factor-beta1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00627.X

Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00627.X

A comparison of normalization methods for high density oligonucleotide array data based on variance and bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00627.X

Cluster analysis and display of genome-wide expression patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00627.X

Post-transplant renal function in the first year predicts long-term kidney transplant survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00627.X

Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation1,2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00627.X

Sirolimus does not exhibit nephrotoxicity compared to cyclosporine in renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00627.X

Can a transplanted living donor kidney function equivalently to its native partner?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00627.X

Molecular and structural consequences of early renal allograft injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00627.X

Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00627.X

Rapamycin is an effective inhibitor of human renal cancer metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00627.X

Expression of TGF-beta and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00627.X

Gene expression fingerprints in human tubulointerstitial inflammation and fibrosis as prognostic markers of disease progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00627.X

Expression of the C-C chemokine receptor 5 in human kidney diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00627.X

Vascular endothelial growth factor expression in human chronic renal allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00627.X

Renoprotective effect of angiotensin II receptor antagonists in experimental chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00627.X

Rapamune® (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00627.X

Nature and mediators of renal lesions in kidney transplant patients given cyclosporine for more than one year

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00627.X

The Banff 97 working classification of renal allograft pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00627.X